OMERACT 10 Sharp Symposium: Important Findings in Examination of Imaging Methods for Measurement of Joint Damage in Rheumatoid Arthritis

The Sharp Symposium was held at the Outcome Measures in Rheumatology Clinical Trials 2010 meeting (OMERACT 10) in honor of the late John Sharp, consummate rheumatologist and researcher. The symposium focused on the status of current scoring methods in radiography, magnetic resonance imaging (MRI), and ultrasound (US) in rheumatoid arthritis (RA), as well as on the use of soluble and tissue biomarkers in RA, with the aim of updating recommendations regarding methods for enhanced detection, monitoring, and prediction of joint damage in clinical trials.

[1]  D. M. van der Heijde,et al.  Damage and Progression on Radiographs in Individual Joints: Data from Pivotal Randomized Controlled Trials , 2011, The Journal of Rheumatology.

[2]  E. Naredo,et al.  A Systematic Literature Review Analysis of Ultrasound Joint Count and Scoring Systems to Assess Synovitis in Rheumatoid Arthritis According to the OMERACT Filter , 2011, The Journal of Rheumatology.

[3]  P. Tak,et al.  Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trials , 2010, Annals of the rheumatic diseases.

[4]  M. Østergaard,et al.  Patterns of MRI Bone Erosion in Rheumatoid Arthritis - Which Bones Are Most Frequently Involved and Show Most Change? , 2010 .

[5]  Carmen D. Donado.  The Journal of Rheumatology , 2010 .

[6]  D. M. van der Heijde,et al.  Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial , 2008, Annals of the rheumatic diseases.

[7]  H. Thomsen,et al.  MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA) , 2008, Annals of the rheumatic diseases.

[8]  K. Patra,et al.  Adalimumab response in patients with early versus established rheumatoid arthritis: DE019 randomized controlled trial subanalysis , 2009, Clinical Rheumatology.

[9]  V. Strand,et al.  Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. , 2008, Arthritis and rheumatism.

[10]  F. Breedveld,et al.  Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial , 2008, The Lancet.

[11]  H. Genant,et al.  Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial , 2007, Annals of the rheumatic diseases.

[12]  F. McQueen.  A vital clue to deciphering bone pathology: MRI bone oedema in rheumatoid arthritis and osteoarthritis , 2007, Annals of the Rheumatic Diseases.

[13]  Franz Kainberger,et al.  Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis. , 2007, Arthritis and rheumatism.

[14]  D. M. van der Heijde,et al.  Repair in rheumatoid arthritis, current status. Report of a workshop at OMERACT 8. , 2007, The Journal of rheumatology.

[15]  L. Klareskog,et al.  Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial , 2004, The Lancet.

[16]  V. Strand,et al.  Radiographic data from recent randomized controlled trials in rheumatoid arthritis: what have we learned? , 2003, Arthritis and rheumatism.

[17]  P. Shekelle,et al.  How to read radiographs according to the Sharp/van der Heijde method. , 1999 .

[18]  H K Genant,et al.  Assessment of rheumatoid arthritis using a modified scoring method on digitized and original radiographs. , 1998, Arthritis and rheumatism.

[19]  J. Moreland,et al.  Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities. , 1971, Arthritis and rheumatism.